<DOC>
	<DOCNO>NCT02872701</DOCNO>
	<brief_summary>This phase 2 , multi-center , single dose , open-label , exploratory study suspect lung cancer patient schedule undergo endoscopic thoracic surgery per CT/positron emission tomography image base standard care . This study aim assess efficacy OTL38 Near Infrared Imaging ( NIR ) identify pulmonary nodule within operating theater , assess safety tolerability single intravenous dos OTL38 .</brief_summary>
	<brief_title>OTL38 Injection Intraoperative Imaging Folate Receptor Positive Lung Nodules</brief_title>
	<detailed_description>This phase 2 , multi-center , single dose , open-label , exploratory study suspect lung cancer patient schedule undergo endoscopic thoracic surgery per CT/positron emission tomography ( PET ) image base standard care . Two three hour prior surgery , patient infuse OTL38 . After patient intubate surgical site incise , surgeon locate document nodule identifiable white light , manual palpation , Near-Infrared Imaging ( NIR ) . This document record . Surgery complete per surgeon 's standard care , afterwards area review standard infrared light . All sample send pathology immunohistochemistry ( IHC ) evaluation .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<criteria>1 . Male Female patient 18 year age old 2 . Confirmed diagnosis adenocarcinoma lung cancer OR , 3 . Have primary diagnosis , high clinical suspicion , lung nodule ( ) warrant surgery base CT and/or PET image 4. Who schedule undergo endoscopic thoracic surgery surgery 5 . A negative serum pregnancy test Screening follow negative urine pregnancy test day surgery day admission female patient childbearing potential 6 . Female patient childbearing potential less 2 year postmenopausal agree use acceptable form contraception time sign informed consent 30 day study completion 7 . Ability understand requirement study , provide write informed consent authorization use disclosure protect health information , agree abide study restriction return require assessment 1 . Previous exposure OTL38 2 . Known Folate Receptornegative lung nodule 3 . Any medical condition opinion investigator could potentially jeopardize safety patient 4 . History anaphylactic reaction severe allergy 5 . History allergy component OTL38 , include folic acid 6 . Pregnancy , positive pregnancy test 7 . Clinically significant abnormality electrocardiogram ( ECG ) screening . 8 . Presence psychological , familial , sociological geographical condition potentially hamper compliance study protocol followup schedule 9 . Impaired renal function define epidermal growth factor receptor ( eGFR ) &lt; 50 mL/min/1.73m2 10 . Impaired liver function define value &gt; 3x upper limit normal ( ULN ) alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) , alkaline phosphatase ( ALP ) , total bilirubin . 11 . Received investigational agent another investigational drug vaccine trial within 30 day prior surgery 12 . Known sensitivity fluorescent light</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>